Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $215,689 | 21 | 93.4% |
| Consulting Fee | $7,150 | 1 | 3.1% |
| Education | $3,115 | 2 | 1.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,994 | 1 | 1.3% |
| Travel and Lodging | $1,978 | 3 | 0.9% |
| Food and Beverage | $14.87 | 1 | 0.0% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Milestone Scientific Inc. | $230,926 | 34 | $0 (2024) |
| PORTOLA PHARMACEUTICALS, INC. | $14.87 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $0 | 1 | Milestone Scientific Inc. |
| 2023 | $2,994 | 2 | Milestone Scientific Inc. ($2,994) |
| 2022 | $35,954 | 5 | Milestone Scientific Inc. ($35,954) |
| 2021 | $145,112 | 18 | Milestone Scientific Inc. ($145,112) |
| 2020 | $8,751 | 4 | Milestone Scientific Inc. ($8,751) |
| 2019 | $38,130 | 5 | MILESTONE SCIENTIFIC INC. ($38,115) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 2024 | Milestone Scientific Inc. | — | — | — | $0.00 | Ownership |
| 12/31/2023 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Dividend, profit or other return on investment | $2,993.75 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 2023 | Milestone Scientific Inc. | — | — | — | $0.00 | Ownership |
| 12/31/2022 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $8,981.25 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 09/30/2022 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $8,988.61 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 06/30/2022 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $8,990.22 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 03/31/2022 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $8,994.08 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 2022 | Milestone Scientific Inc. | — | — | — | $0.00 | Ownership |
| 12/31/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.58 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 12/03/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Consulting Fee | Cash or cash equivalent | $7,150.00 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 11/30/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.21 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 10/31/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.05 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 09/30/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.40 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 08/31/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.39 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 07/31/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.53 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 07/14/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Travel and Lodging | Cash or cash equivalent | $1,028.94 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 07/14/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Travel and Lodging | Cash or cash equivalent | $506.46 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 07/14/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Travel and Lodging | Cash or cash equivalent | $442.58 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 06/30/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.79 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 05/31/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.56 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 04/30/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.81 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 03/31/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,999.16 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 02/28/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,999.23 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 01/31/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $2,998.94 | General |
| Category: EPIDURAL INJECTIONS | ||||||
| 01/21/2021 | Milestone Scientific Inc. | COMPUFLO EPIDURAL (Device) | Current or prospective ownership or investment interest | Dividend, profit or other return on investment | $100,000.00 | General |
| Category: EPIDURAL INJECTIONS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 137 | 142 | $66,012 | $12,396 |
| 2022 | 8 | 181 | 184 | $91,389 | $16,639 |
| 2021 | 1 | 13 | 21 | $5,397 | $1,215 |
| 2020 | 7 | 331 | 348 | $93,282 | $33,338 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 98 | 99 | $56,430 | $10,055 | 17.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 26 | 30 | $7,710 | $1,872 | 24.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 13 | $1,872 | $469.68 | 25.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 55 | 55 | $31,350 | $5,915 | 18.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 17 | 17 | $11,730 | $2,505 | 21.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 19 | 19 | $14,820 | $1,947 | 13.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 24 | 24 | $8,232 | $1,922 | 23.4% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $8,976 | $1,680 | 18.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 25 | $6,425 | $1,359 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 16 | 16 | $8,128 | $940.24 | 11.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 12 | $1,728 | $369.65 | 21.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 21 | $5,397 | $1,215 | 22.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 110 | 113 | $47,121 | $18,150 | 38.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 55 | 57 | $16,148 | $6,100 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 53 | $7,950 | $3,110 | 39.1% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 49 | 49 | $10,976 | $2,746 | 25.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Facility | 2020 | 39 | 39 | $6,162 | $1,601 | 26.0% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 23 | 23 | $2,783 | $1,050 | 37.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 14 | 14 | $2,142 | $580.72 | 27.1% |
About Dr. Abraham Scheer, MD
Dr. Abraham Scheer, MD is a Neurology healthcare provider based in Dover, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1124195417.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abraham Scheer, MD has received a total of $230,940 in payments from pharmaceutical and medical device companies, with $0 received in 2024. These payments were reported across 35 transactions from 2 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($215,689).
As a Medicare-enrolled provider, Scheer has provided services to 662 Medicare beneficiaries, totaling 695 services with total Medicare billing of $63,589. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Neurology
- Location Dover, DE
- Active Since 11/29/2006
- Last Updated 10/24/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1124195417
Products in Payments
- COMPUFLO EPIDURAL (Device) $230,926
- ANDEXXA (Biological) $14.87
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Dover
Alok Bhagat, M.d, M.D
Neurology — Payments: $8,427
Wayne Greene, Md, MD
Neurology — Payments: $4,869
Marcia Dover, Md, MD
Neurology — Payments: $4,402
Dr. Robert Varipapa, M.d, M.D
Neurology — Payments: $3,196
Stephen Penny, Md, MD
Neurology — Payments: $2,390
Infanta Stephen, Md, MD
Neurology — Payments: $2,240